UNAIDS/WHO 2015 | Reference
WHO working group on HIV incidence assays meeting report
10–11 December 2015
Glion, Switzerland
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance
WHO/HIV/2017.03
This document aims to provide global guidance on poliomyelitis (polio) surveillance in the context of the COVID-19 pandemic. It comes as a technical complement to Polio eradication programme continuity, Immunization in the context of COVID-19 pandemic frequently asked questions, and is aligned with ...the Global Polio Eradication Initiative (GPEI) commitment to support the COVID-19 pandemic response.
It highlights the decision making framework to guide the level of polio surveillance activities at country level including; the measures to put in place to ensure a minimum level of polio surveillance in the field and in the laboratory, and the trigger to return to normal polio function.
more
Cette formation a pour but de renforcer les capacités des acteurs communautaires sur la surveillance intégrée des maladies a potentiel épidémique.
Il s'avère nécessaire de former de manière adéquate les acteur communautaires et de mettre en place un système performant de surveillance int...égrée des maladies aux niveau communautaires soutenu par une communication appropriée avec les population aussi bien au milieu urbain que rural.
more
Technical Brief
HIV patient monitoring and case surveillance
WHO/HIV/2017.11
Participant Manual September 2009
Therapeutics Information and Pharmacovigilance Centre | TIPC
HIV patient monitoring and case surveillance
March 2020
The number of African Union Member States reporting COVID-
19 cases is increasing and there is a likelihood of community transmission. The WHO recently modified the COVID-19 suspect case definition to include severe acute respiratory infection and advises testing of all severe acute r...espiratory illness (SARI) cases.1 However, many Member States have not yet started implementing these changes, they are still focussing surveillance efforts on individuals with travel history to an area with local COVID-19 transmission. This means patients with similar symptoms, but no apparent contact, may not
be investigated.
more